Beam Therapeutics Opens with $87-million for CRISPR Innovations – Edgy Labs (blog)
Edgy Labs (blog) |
Beam Therapeutics Opens with $87-million for CRISPR Innovations
Edgy Labs (blog) CRISPR-Cas9 is the strep-bacteria-derived gene-editing biotech sweeping the scientific world. We have written about it on many occasions, so feel free to re-familiarize yourself. Hint: you might recognize some names in those articles and this one. CRISPR Therapeutics Announces Presentations at the ASGCT 21st Annual Meeting Premarket analyst action – healthcare What Traders Are Missing About United States Steel Corporation (X), CRISPR Therapeutics AG (CRSP) |
